New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
07:20 EDTNVDQNovadaq shares should be bought after miss, says JMP Securities
After Novadaq reported weaker than expected Q2 results, JMP Securities is encouraged by the company's focus on clinical trials and remains upbeat about the clinical value of its SPY fluorescence technology. Consequently, the firm continues to recommend buying the shares.
News For NVDQ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NVDQ

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use